AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31251094 — intervention group
Group type: COMPARATOR
Intervention: Within-study severe exacerbations (MUSCA)
Number of subjects: 1755
Study 30656873 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training
Number of subjects: 0
Study 30656873 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional training)
Number of subjects: 0
Study 28698994 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 184
Study 28698994 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium dipping group (n = 100; 54.3%)
Number of subjects: 184
Study 28698994 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium dipping group
Number of subjects: 184
Study 25743173 — intervention group
Group type: EXPERIMENTAL
Intervention: Anacetrapib 100 mg
Number of subjects: 306
Study 25743173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306
Study 25743173 — intervention group
Group type: EXPERIMENTAL
Intervention: Anacetrapib
Number of subjects: 306
Study 24613523 — intervention group
Group type: EXPERIMENTAL
Intervention: BioThrax® (anthrax vaccine adsorbed) administered subcutaneously (SC) in a three-dose regimen (0, 2, and 4 weeks)
Number of subjects: 200
Study 22980315 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitopertin 30 mg
Number of subjects: 169
Study 22980315 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitopertin 175 mg
Number of subjects: 169
Study 22980315 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 169
Study 22980315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study 19709418 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 841
Study 19709418 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorproguanil-dapsone (CPD)
Number of subjects: 841
Study 19709418 — intervention group
Group type: COMPARATOR
Intervention: Sulphadoxine-pyrimethamine (SP)
Number of subjects: 841
Study 17599875 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 57
Study 17599875 — intervention group
Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 57
Study 15226466 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavones from red clover-derived dietary supplement (43.5 mg/d)
Number of subjects: 205
Study 15226466 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study 12206944 — intervention group
Group type: COMPARATOR
Intervention: Ankle braces
Number of subjects: 24
Study 9523247 — intervention group
Group type: EXPERIMENTAL
Intervention: Styrene exposure (high-level exposure)
Number of subjects: 22
Study 9523247 — intervention group
Group type: COMPARATOR
Intervention: Control (unexposed subjects)
Number of subjects: 22
Study 9523247 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level exposure (MA + PGA < or = 159 mg/g creatinine)
Number of subjects: 22
Study 9523247 — intervention group
Group type: EXPERIMENTAL
Intervention: High-level exposure (MA + PGA > 159 mg/g creatinine)
Number of subjects: 22
Study 8595636 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil suspension 30 mg/kg per day in two divided doses (n = 235)
Number of subjects: 477
Study 8595636 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate suspension 40 mg/kg per day in three divided doses (n = 242)
Number of subjects: 477
Study 8595636 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil suspension (bacteriologically assessable patients)
Number of subjects: 477
Study 8595636 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate suspension (bacteriologically assessable patients)
Number of subjects: 477
Study 8595636 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil suspension
Number of subjects: 477
Study 8595636 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate suspension
Number of subjects: 477
Study 2597656 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservation of the posterior branch of the great auricular nerve
Number of subjects: 12
Study 2597656 — intervention group
Group type: COMPARATOR
Intervention: Sacrifice of the posterior branch of the great auricular nerve
Number of subjects: 12
Study 6107157 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 8
Study 6107157 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 8
Study 30451342 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrofurazone-coated silicone urinary catheter
Number of subjects: 214
Study 30451342 — intervention group
Group type: COMPARATOR
Intervention: Non-impregnated silicone urinary catheter
Number of subjects: 214
Study 28249980 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 176
Study 28249980 — intervention group
Group type: COMPARATOR
Intervention: Non-operative treatment
Number of subjects: 176
Study 25851433 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine powder air-polishing (GPAP)
Number of subjects: 37
Study 25851433 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic (US) debridement
Number of subjects: 37
Study 24730013 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS visible (BIS value shown throughout the procedure)
Number of subjects: 0
Study 24730013 — intervention group
Group type: COMPARATOR
Intervention: BIS not visible (BIS hidden, monitoring based on clinical signs and expiratory fraction of halogenated anesthetic agents)
Number of subjects: 0
Study 23189308 — intervention group
Group type: COMPARATOR
Intervention: PAB (autogenous particulated bone)
Number of subjects: 30
Study 23189308 — intervention group
Group type: EXPERIMENTAL
Intervention: PAB + beta‐tricalcium phosphate (Β‐TCP)
Number of subjects: 30
Study 23189308 — intervention group
Group type: EXPERIMENTAL
Intervention: PAB + beta‐tricalcium phosphate (Β‐TCP) + hydroxyapatite (HA)
Number of subjects: 30
Study 20451774 — intervention group
Group type: EXPERIMENTAL
Intervention: First Class Appliance (FCA)
Number of subjects: 26
Study 20451774 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated group)
Number of subjects: 26
Study 18625674 — intervention group
Group type: EXPERIMENTAL
Intervention: Cylinder oxygen
Number of subjects: 20
Study 18625674 — intervention group
Group type: COMPARATOR
Intervention: Cylinder air
Number of subjects: 20
Study 16203934 — intervention group
Group type: EXPERIMENTAL
Intervention: MCV-4
Number of subjects: 881
Study 16203934 — intervention group
Group type: COMPARATOR
Intervention: PSV-4
Number of subjects: 881
Study 12236607 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel sleep aid
Number of subjects: 80
Study 10090538 — intervention group
Group type: COMPARATOR
Intervention: Formula-fed infants
Number of subjects: 100
Study 10090538 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfed infants
Number of subjects: 100
Study 7811176 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaproterenol (80 mg/day)
Number of subjects: 10
Study 7811176 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2349369 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (single dose equivalent to two to four cups of coffee)
Number of subjects: 0
Study 2349369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7273596 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg brotizolam
Number of subjects: 11
Study 7273596 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg brotizolam
Number of subjects: 11
Study 7273596 — intervention group
Group type: COMPARATOR
Intervention: 10 mg flurazepam
Number of subjects: 11
Study 7273596 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 31067587 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy by PTs with varying experience (2 to 21 years)
Number of subjects: 79
Study 31449992 — intervention group
Group type: EXPERIMENTAL
Intervention: Microelectrode recording (MER)
Number of subjects: 273
Study 31449992 — intervention group
Group type: COMPARATOR
Intervention: Control (initial anatomic target, AT)
Number of subjects: 273
Study 28657870 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 786
Study 28657870 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 786
Study 28657870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 786
Study 28657870 — intervention group
Group type: EXPERIMENTAL
Intervention: TMP-SMX
Number of subjects: 786
Study 26201184 — intervention group
Group type: EXPERIMENTAL
Intervention: UPPP oriented surgery in cognitive dysfunction group
Number of subjects: 44
Study 26201184 — intervention group
Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 44
Study 26201184 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive dysfunction group
Number of subjects: 44
Study 26201184 — intervention group
Group type: COMPARATOR
Intervention: Cognitively normal group
Number of subjects: 44
Study 23116051 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 30
Study 23116051 — intervention group
Group type: COMPARATOR
Intervention: Prescribed Advice (PA)
Number of subjects: 30
Study 21409383 — intervention group
Group type: EXPERIMENTAL
Intervention: XELOX + BV
Number of subjects: 64
Study 21409383 — intervention group
Group type: COMPARATOR
Intervention: FOLFOX-4 + BV
Number of subjects: 64
Study 21409383 — intervention group
Group type: EXPERIMENTAL
Intervention: Both XELOX + BV and FOLFOX-4 + BV
Number of subjects: 64
Study 19288942 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhomboid excision and Limberg flap (group B)
Number of subjects: 49
Study 19288942 — intervention group
Group type: COMPARATOR
Intervention: Open excision and secondary healing (group A)
Number of subjects: 49
Study 17614893 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of didactic guidelines and netiquette advice
Number of subjects: 112
Study 17614893 — intervention group
Group type: COMPARATOR
Intervention: Netiquette advice only
Number of subjects: 112
Study 17614893 — intervention group
Group type: COMPARATOR
Intervention: Trivial information guidelines
Number of subjects: 112
Study 14984379 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine discontinued
Number of subjects: 34
Study 11351930 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular buprenorphine/naloxone (1/0.25, 2/0.5, 4/1, 8/2, 16/4 mg)
Number of subjects: 8
Study 11351930 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine/naloxone (1/0.25, 2/0.5, 4/1, 8/2, 16/4 mg)
Number of subjects: 8
Study 11351930 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular hydromorphone (10 mg) and naloxone (0.25 mg)
Number of subjects: 8
Study 11351930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 11351930 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular buprenorphine alone (8 mg)
Number of subjects: 8
Study 11351930 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine alone (8 mg)
Number of subjects: 8
Study 9135734 — intervention group
Group type: EXPERIMENTAL
Intervention: pCMV‐CFTR:2.4 mg DOTAP (400 micrograms)
Number of subjects: 16
Study 9135734 — intervention group
Group type: COMPARATOR
Intervention: Buffer only (control)
Number of subjects: 16
Study 8198341 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-1A
Number of subjects: 621
Study 8198341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 621
Study 2823594 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllium gum
Number of subjects: 12
Study 2823594 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of psyllium gum and wheat bran
Number of subjects: 12
Study 2823594 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bran
Number of subjects: 12
Study 2823594 — intervention group
Group type: COMPARATOR
Intervention: Control (4 g/d fiber)
Number of subjects: 12
Study 31923556 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual care interventions
Number of subjects: 19
Study 31923556 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 19
Study 29859267 — intervention group
Group type: EXPERIMENTAL
Intervention: TeleCAM (home-based telerehabilitation intervention using pre-loaded tablets and IVR system technology)
Number of subjects: 820
Study 29859267 — intervention group
Group type: COMPARATOR
Intervention: DirectCAM (clinic-based intervention delivered by a therapist)
Number of subjects: 820
Study 27662565 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily sedation interruption + protocolized sedation
Number of subjects: 64
Study 27662565 — intervention group
Group type: COMPARATOR
Intervention: Protocolized sedation only
Number of subjects: 64
Study 27662565 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily sedation interruption + protocolized sedation (for children > 4 years old)
Number of subjects: 64
Study 25693004 — intervention group
Group type: EXPERIMENTAL
Intervention: Allisartan Isoproxil 240mg
Number of subjects: 275
Study 25693004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study 22288788 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy group (n = 14)
Number of subjects: 28
Study 22288788 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 14)
Number of subjects: 28
Study 22288788 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups after eccentric exercise
Number of subjects: 28
Study 22288788 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups after second eccentric exercise bout
Number of subjects: 28
Study 22288788 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study 22402092 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient treatment
Number of subjects: 0
Study 22402092 — intervention group
Group type: EXPERIMENTAL
Intervention: Day hospital treatment
Number of subjects: 0
Study 22402092 — intervention group
Group type: EXPERIMENTAL
Intervention: ISE measures
Number of subjects: 0
Study 17697398 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g short-chain fructo-oligosaccharides (sc-FOS) per day for 6 weeks
Number of subjects: 105
Study 17697398 — intervention group
Group type: COMPARATOR
Intervention: 5 g placebo (sucrose and maltodextrins) per day for 6 weeks
Number of subjects: 105
Study 16302654 — intervention group
Group type: EXPERIMENTAL
Intervention: Defunctioning colostomy
Number of subjects: 104
Study 16302654 — intervention group
Group type: EXPERIMENTAL
Intervention: Hartmann procedure
Number of subjects: 104
Study 16302654 — intervention group
Group type: EXPERIMENTAL
Intervention: Diverting colostomy
Number of subjects: 104
Study 16302654 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative morbidity
Number of subjects: 104
Study 16302654 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative mortality
Number of subjects: 104
Study 16302654 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastomotic leak
Number of subjects: 104
Study 16302654 — intervention group
Group type: EXPERIMENTAL
Intervention: Reintervention
Number of subjects: 104
Study 16302654 — intervention group
Group type: EXPERIMENTAL
Intervention: Major stoma related complications
Number of subjects: 104
Study 11840286 — intervention group
Group type: EXPERIMENTAL
Intervention: GSTT1(+)
Number of subjects: 193
Study 11840286 — intervention group
Group type: COMPARATOR
Intervention: GSTT1(-)
Number of subjects: 193
Study 11840286 — intervention group
Group type: EXPERIMENTAL
Intervention: GSTT1(+) and GSTT1(-)
Number of subjects: 193
Study 10635157 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-transitional implants (MTIs) placed medially to the permanent implants.
Number of subjects: 12
Study 10635157 — intervention group
Group type: EXPERIMENTAL
Intervention: MTI-supported dentures
Number of subjects: 12
Study 8544287 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane 1.0 % in oxygen (O2)
Number of subjects: 31
Study 8544287 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane 1.0 % with 67 % N2O in O2
Number of subjects: 31
Study 8544287 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane 1.7 % in O2
Number of subjects: 31
Study 8544287 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane 0.7 % with 67 % N2O in O2
Number of subjects: 31
Study 8544287 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of fentanyl and midazolam with 67 % N2O
Number of subjects: 31
Study 8544287 — intervention group
Group type: COMPARATOR
Intervention: Intravenous administration of fentanyl and midazolam without N2O
Number of subjects: 31
Study 1673645 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 100 mg
Number of subjects: 12
Study 1673645 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 200 mg
Number of subjects: 12
Study 1673645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7083512 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg
Number of subjects: 12
Study 31727641 — intervention group
Group type: EXPERIMENTAL
Intervention: High user ratings (4, 5 stars)
Number of subjects: 400
Study 31727641 — intervention group
Group type: COMPARATOR
Intervention: Low user ratings (1, 2, 3 stars)
Number of subjects: 400
Study 31727641 — intervention group
Group type: COMPARATOR
Intervention: App store (iTunes vs Google Play)
Number of subjects: 400
Study 28401617 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisis resource management principles and team debriefing in simulation training
Number of subjects: 116
Study 28401617 — intervention group
Group type: COMPARATOR
Intervention: Control group (only simulation training)
Number of subjects: 116
Study 27579634 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate plus salmeterol
Number of subjects: 6208
Study 27579634 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate alone
Number of subjects: 6208
Study 24119775 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training for 2 weeks with increasing velocity
Number of subjects: 23
Study 22664648 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtable™ EMR-integrated tool for medication management
Number of subjects: 0
Study 22664648 — intervention group
Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 0
Study 19598056 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intention condition
Number of subjects: 35
Study 19598056 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 35
Study 16433927 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion intervention over 6 months
Number of subjects: 1013
Study 16433927 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1013
Study 16433927 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion intervention
Number of subjects: 1013
Study 14583064 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine (10-20 mg daily)
Number of subjects: 0
Study 14583064 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 0
Study 10839660 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamins
Number of subjects: 1083
Study 10839660 — intervention group
Group type: COMPARATOR
Intervention: No multivitamins
Number of subjects: 1083
Study 10839660 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A
Number of subjects: 1083
Study 10839660 — intervention group
Group type: COMPARATOR
Intervention: No vitamin A
Number of subjects: 1083
Study 8985799 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (CR) programs after myocardial infarction (MI)
Number of subjects: 2740
Study 8985799 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (CR) programs after coronary angioplasty (PTCA)
Number of subjects: 2740
Study 8985799 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (CR) programs after coronary artery bypass surgery (CABS)
Number of subjects: 2740
Study 8985799 — intervention group
Group type: COMPARATOR
Intervention: Post-MI women enrollment in CR programs
Number of subjects: 2740
Study 8985799 — intervention group
Group type: COMPARATOR
Intervention: Post-CABS women enrollment in CR programs
Number of subjects: 2740
Study 1284156 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallopamil (50 mg t.i.d. for 4 weeks)
Number of subjects: 22
Study 1284156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 6377491 — intervention group
Group type: EXPERIMENTAL
Intervention: Orgotein 16 mg
Number of subjects: 36
Study 6377491 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone acetate 40 mg
Number of subjects: 36
Study 6377491 — intervention group
Group type: EXPERIMENTAL
Intervention: Orgotein 8 mg
Number of subjects: 36
Study 31115688 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone-bupivacaine
Number of subjects: 120
Study 31115688 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 120
Study 31115688 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 120
Study 30081380 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine infusion
Number of subjects: 71
Study 30081380 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg ketamine infusion
Number of subjects: 71
Study 30081380 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 71
Study 26695494 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotropic medications
Number of subjects: 88
Study 26695494 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpsychotropic medications
Number of subjects: 88
Study 24913351 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (30 min at moderate intensity on a bicycle ergometer)
Number of subjects: 30
Study 24913351 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 30
Study 22885073 — intervention group
Group type: EXPERIMENTAL
Intervention: Previews of the surrounding environment given prior to some trials
Number of subjects: 0
Study 22885073 — intervention group
Group type: EXPERIMENTAL
Intervention: Egocentric frame of reference
Number of subjects: 0
Study 22885073 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial memory derived from vision or spatial language
Number of subjects: 0
Study 21308265 — intervention group
Group type: EXPERIMENTAL
Intervention: Piper methysticum
Number of subjects: 0